Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes

A Drilon, ZI Hu, GGY Lai, DSW Tan - Nature reviews Clinical oncology, 2018 - nature.com
The gene encoding the receptor-tyrosine kinase RET was first discovered more than three
decades ago, and activating RET rearrangements and mutations have since been identified …

RET revisited: expanding the oncogenic portfolio

LM Mulligan - Nature Reviews Cancer, 2014 - nature.com
The RET receptor tyrosine kinase is crucial for normal development but also contributes to
pathologies that reflect both the loss and the gain of RET function. Activation of RET occurs …

Biology of GDNF and its receptors—relevance for disorders of the central nervous system

CF Ibáñez, JO Andressoo - Neurobiology of disease, 2017 - Elsevier
A targeted effort to identify novel neurotrophic factors for midbrain dopaminergic neurons
resulted in the isolation of GDNF (glial cell line-derived neurotrophic factor) from the …

Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo

P Lindholm, MH Voutilainen, J Laurén, J Peränen… - Nature, 2007 - nature.com
In Parkinson's disease, brain dopamine neurons degenerate most prominently in the
substantia nigra. Neurotrophic factors promote survival, differentiation and maintenance of …

Nurr1 is required for maintenance of maturing and adult midbrain dopamine neurons

B Kadkhodaei, T Ito, E Joodmardi… - Journal of …, 2009 - Soc Neuroscience
Transcription factors involved in the specification and differentiation of neurons often
continue to be expressed in the adult brain, but remarkably little is known about their late …

c-Jun in Schwann cells promotes axonal regeneration and motoneuron survival via paracrine signaling

X Fontana, M Hristova, C Da Costa, S Patodia… - Journal of Cell …, 2012 - rupress.org
The AP-1 transcription factor c-Jun is a master regulator of the axonal response in neurons.
c-Jun also functions as a negative regulator of myelination in Schwann cells (SCs) and is …

α-Synuclein–induced down-regulation of Nurr1 disrupts GDNF signaling in nigral dopamine neurons

M Decressac, B Kadkhodaei, B Mattsson… - Science translational …, 2012 - science.org
Glial cell line–derived neurotrophic factor (GDNF) and its close relative neurturin are
currently in clinical trials for neuroprotection in patients with Parkinson disease (PD) …

NURR1 in Parkinson disease—from pathogenesis to therapeutic potential

M Decressac, N Volakakis, A Björklund… - Nature Reviews …, 2013 - nature.com
In Parkinson disease (PD), affected midbrain dopamine (DA) neurons lose specific
dopaminergic properties before the neurons die. How the phenotype of DA neurons is …

[HTML][HTML] Dopaminergic neurons and brain reward pathways: from neurogenesis to circuit assembly

SX Luo, EJ Huang - The American journal of pathology, 2016 - Elsevier
Midbrain dopaminergic (DA) neurons in the substantia nigra pars compacta and ventral
tegmental area regulate extrapyramidal movement and important cognitive functions …

Neuron-glia communication via EphA4/ephrin-A3 modulates LTP through glial glutamate transport

A Filosa, S Paixão, SD Honsek, MA Carmona… - Nature …, 2009 - nature.com
Astrocytes are critical participants in synapse development and function, but their role in
synaptic plasticity is unclear. Eph receptors and their ephrin ligands have been suggested to …